Merck & Co. Inc. Unveils $1 Billion Investment in Delaware for New Drug Manufacturing Facility

Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce drugs, including a new version of Keytruda, creating 4,500 jobs by 2030, aligning with US d...